Novum

Novum is a full-service CRO with an impeccable performance record and numerous FDA approvals in new drug, 505(b)(2) and ANDA submissions. We manage complex studies across numerous therapeutic areas and dosage forms, spanning early phase to late phase trials. With the full integration of our bioanalytical unit in Toronto, Canada in 2020, Novum is poised to continue its longstanding tradition of serving clients with safety, quality, and scientific leadership.